PTCT
PTC Therapeutics Inc.
$67.65
-$1.16(-1.69%)
54
Overall
60
Value
45
Tech
57
Quality
Market Cap
$5.27B
Volume
1.00M
52W Range
$43.18 - $87.50
Target Price
$90.60
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $82.7M | $194.4M | $264.7M | $307.0M | $380.8M | $538.6M | $698.8M | $937.8M | $806.8M | $1.7B | ||
| Total Revenue | $81.4M | $194.4M | $264.7M | $307.0M | $380.8M | $538.6M | $698.8M | $937.8M | $806.8M | $1.7B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | $-4.6M | $-12.7M | $400.0K | $18.9M | $32.3M | $44.7M | $65.5M | $57.4M | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $82.7M | $-4.6M | $-12.7M | $307.0M | $361.8M | $506.3M | $654.1M | $937.8M | $806.8M | $1.7B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-214.8M | $-258.7M | $-380.4M | $548.1M | $812.5M | $913.0M | $1.1B | $1.4B | $1.1B | $863.7M | ||
| Research & Development | $117.6M | $117.5M | $172.0M | $257.5M | $477.6M | $540.7M | $651.5M | $666.6M | $534.5M | $455.2M | ||
| Research Expense | $117.6M | $117.5M | $172.0M | $257.5M | $477.6M | $540.7M | $651.5M | $666.6M | $534.5M | $455.2M | ||
| Selling, General & Administrative | $97.1M | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | $347.1M | ||
| Selling & Marketing Expenses | -- | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | -- | -- | -- | -- | ||
| General & Administrative Expenses | $97.1M | $-2.2M | $-2.7M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | $347.1M | ||
| Salaries & Wages | $-35.0M | $-30.6M | $-33.3M | $-42.1M | $-70.3M | $-103.5M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-3.3M | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | $24.7M | ||
| Depreciation & Amortization | $-3.3M | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | $24.7M | ||
| Amortization | $-302.0K | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | $24.7M | ||
| Other Operating Expenses | $-214.8M | $-258.7M | $-380.4M | $-12.1M | $-29.6M | $-32.3M | $-44.7M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-132.1M | $-258.7M | $-361.1M | $-241.2M | $-431.8M | $-374.4M | $-447.4M | $-439.5M | $-302.6M | $866.9M | ||
| EBITDA | $-136.1M | $-59.0M | $-101.9M | $-205.3M | $-303.1M | $-368.2M | $-356.0M | $-318.6M | $-111.5M | $896.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $56.4M | $86.0M | $90.9M | $129.2M | $167.0M | $152.2M | ||
| Intinc | $-8.3M | $-12.1M | $-12.6M | $-12.5M | $-56.4M | $-86.0M | $-90.9M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-8.3M | $-12.1M | $-12.6M | $-12.5M | $-56.4M | $-86.0M | $-90.9M | $-129.2M | $-167.0M | $-152.2M | ||
| Gain on Sale of Securities | -- | -- | -- | $2.2M | $700.0K | $800.0K | $4.0M | -- | -- | -- | ||
| Other Income/Expense | $1.2M | $-193.1M | $-245.5M | $34.6M | $-61.9M | $57.4M | $-56.7M | $217.5M | $148.5M | $17.3M | ||
| Other Special Charges | $-1.2M | $193.1M | $264.9M | $13.7M | $85.2M | $-57.9M | $-49.2M | $-127.4M | $6.5M | $-18.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | $6.8M | $7.5M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $33.4M | $217.8M | $159.5M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-141.5M | $-77.7M | $-128.1M | $-239.9M | $-346.6M | $-432.3M | $-496.6M | $-566.9M | $-196.1M | $848.8M | ||
| Pre-Tax Income | $-141.5M | $-77.7M | $-128.1M | $-239.9M | $-402.9M | $-518.3M | $-587.5M | $-696.1M | $-363.1M | $696.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $569.0K | $1.3M | $-29.0K | $11.7M | $35.2M | $5.6M | $-28.5M | $-69.5M | $176.0K | $14.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | $682.6M | ||
| Net Income (Continuing Operations) | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | $682.6M | ||
| Net Income (Discontinued Operations) | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | $682.6M | ||
| Net Income (Common Stockholders) | $-142.1M | $-79.0M | $-128.1M | $-227.3M | $-379.1M | $-459.2M | $-559.0M | $-626.6M | $-363.3M | $682.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $688.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-214.8M | $-263.3M | $-393.1M | $548.5M | $813.0M | $915.2M | $1.1B | $1.4B | $1.1B | $863.7M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $34.0M | $39.2M | $46.6M | $58.9M | $66.0M | $70.5M | $71.7M | $74.8M | $76.8M | $79.5M | ||
| Average Shares Outstanding (Diluted) | $34.1M | $39.1M | $46.6M | $58.9M | $66.0M | $70.5M | $71.7M | $74.8M | $76.8M | $88.3M | ||
| Shares Outstanding | $34.6M | $41.8M | $58.4M | $62.6M | $70.3M | $71.4M | $73.8M | $76.6M | $78.9M | $82.8M | ||
| Basic EPS | -- | -- | -- | $-4.27 | -- | $-7.43 | $-7.79 | $-8.37 | $-4.73 | $8.58 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-7.79 | $-8.37 | $-4.73 | $8.58 | ||
| Diluted EPS | $-4.17 | $-2.02 | $-2.75 | $-4.27 | $-6.64 | $-7.43 | $-7.79 | $-8.37 | $-4.73 | $7.78 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-7.79 | $-8.37 | $-4.73 | $7.78 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of P P E | -- | $-5.0K | $-2.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $97.1M | $-2.2M | $-2.7M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | $347.1M | ||
| Rent And Landing Fees | $97.1M | $121.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | -- | -- | -- | -- | ||
| Othspecchg | -- | $-6.8M | $-7.5M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTCT | $67.65 | -1.7% | 1.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |